Expression of c-Myc, TGF-α and EGF-Receptor in Sporadic Medullary Thyroid Carcinoma

Authors

  • Wenliang Wang Department of Pathology, University Hospital, Uppsala, Sweden; Department of Pathology, 4th Military Medical University, Xian, PR, China
  • Henry E. Johansson Department of Surgery, University Hospital, Uppsala, Sweden
  • Ulla I. Bergholm Department of Pathology, University Hospital, Uppsala, Sweden
  • Kerstin M. Westermark Department of Internal Medicine, University Hospital, Uppsala, Sweden
  • Lars E. Grimelius Department of Pathology, University Hospital, Uppsala, Sweden

DOI:

https://doi.org/10.3109/02841869709001288

Abstract

In 20 patients with sporadic medullary thyroid carcinoma (MTC), immuno-histochemistry was used to localize the expression of the c-Myc oncoprotein, transforming growth factor alpha (TGF-α) and epidermal growth factor receptor (EGFR) and these three markers were analysed regarding their relation to histopathological and histochemical variables of the tumours. The detection rates of c-Myc. TGF-α and EGFR were 90%, 90% and 95% respectively. Concomitant demonstration of the markers was reflected in significant associations (correlation factor between TGF-α and EGFR was 0.93, p < 0.001). The markers were almost invariably located within the cytoplasm, which might suggest their crucial role in growth regulation and cell differentiation; this seems especially true of TGF-α and EGFR. The different markers showed no relation to either histopathological or histochemical variables (tumour behaviour, tumour size, tumour cell type). The prominent co-expression of c-Myc, TGF-α and EGFR proteins indicates that in MTC these factors might be of importance for tumour cell proliferation via autocrine growth stimulation.

Downloads

Download data is not yet available.

Downloads

Published

1997-01-01

How to Cite

Wang, W., Johansson, H. E., Bergholm, U. I., Westermark, K. M., & Grimelius, L. E. (1997). Expression of c-Myc, TGF-α and EGF-Receptor in Sporadic Medullary Thyroid Carcinoma. Acta Oncologica, 36(4), 407–411. https://doi.org/10.3109/02841869709001288